EcoDrugPlus

Integrin Subunit Alpha 4

Ensembl ID : ENSDLEG00000011455
Gene Symbol: ITGA4
3 Cross references
237 Possible Orthologues:

Integrin Subunit Alpha 5

Ensembl ID : ENSDLEG00000006678
Gene Symbol: ITGA5
3 Cross references
267 Possible Orthologues:

Integrin Subunit Alpha V

Ensembl ID : ENSDLEG00000011966
Gene Symbol: ITGAV
3 Cross references
243 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSDLEG00000004934
Gene Symbol: ITGB1
3 Cross references
301 Possible Orthologues:

Integrin Subunit Beta 3

Ensembl ID : ENSDLEG00000003955
Gene Symbol: ITGB3
3 Cross references
268 Possible Orthologues:

Integrin Subunit Beta 5

Ensembl ID : ENSDLEG00000018618
Gene Symbol: ITGB5
3 Cross references
211 Possible Orthologues:

Integrin Subunit Beta 6

Ensembl ID : ENSDLEG00000021846
Gene Symbol: ITGB6
3 Cross references
205 Possible Orthologues:

Integrin Subunit Beta 7

Ensembl ID : ENSDLEG00000004036
Gene Symbol: ITGB7
3 Cross references
159 Possible Orthologues:

Integrin Subunit Beta 8

Ensembl ID : ENSDLEG00000020850
Gene Symbol: ITGB8
3 Cross references
207 Possible Orthologues:

Intercellular Adhesion Molecule 1

Ensembl ID : ENSDLEG00000008458
Gene Symbol: ICAM1
3 Cross references
92 Possible Orthologues:

Interleukin 1 Receptor Associated Kinase 4

Ensembl ID : ENSDLEG00000006336
Gene Symbol: IRAK4
3 Cross references
202 Possible Orthologues:

Interleukin 5

Ensembl ID : ENSDLEG00000002536
Gene Symbol: IL5
1 Cross references
91 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).